의약품이상사례보고시스템 데이터베이스를 이용한 피나스테리드의 약물유해반응 실마리 정보 탐색
Signal Detection for Adverse Events of Finasteride Using Korea Adverse Event Reporting System (KAERS) Database
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
To investigate signals of adverse drug reactions of finasteride by using the Korea Adverse Events Reporting System (KAERS) database. This pharmacovigilance was based on the database of the drug-related adverse reactions reported spontaneously to the KAERS from 2013 to 2017. This study was conducted by disproportionality analysis. Data mining analysis was performed to detect signals of finasteride. The signal was defined by three criteria as proportional reporting ratio (PRR), reporting odds ratio (ROR), and information component (IC). The signals of finasteride were compared with those of the other drugs; dutasteride (similar mechanism of action), minoxidil (different mechanism but similar indications for alopecia), silodosin (different mechanism but similar indications for BPH). It was examined whether the detected signals exist in drug labels in Korea. The total number of adverse eventdrug pairs was reported 2,665,429 from 2013 to 2017, of which 1,426 were associated with finasteride. The number of investigated signals of finasteride was 42. The signals that did not include in the drug label were 29 signals, including mouth dry, hypotension, dysuria etc. The signal of finasteride was similar to that of dutasteride and silodosin but was different to that of minoxidil. Early detection of signals through pharmacovigilance is important to patient safety. We investigated 29 signals of finasteride that do not exist in drug labels in Korea. Further pharmacoepidemiological studies should be needed to evaluate the signal causality with finasteride.
Abstract
To investigate signals of adverse drug reactions of finasteride by using the Korea Adverse Events Reporting System (KAERS) database. This pharmacovigilance was based on the database of the drug-related adverse reactions reported spontaneously to the KAERS from 2013 to 2017. This study was conducted by disproportionality analysis. Data mining analysis was performed to detect signals of finasteride. The signal was defined by three criteria as proportional reporting ratio (PRR), reporting odds ratio (ROR), and information component (IC). The signals of finasteride were compared with those of the other drugs; dutasteride (similar mechanism of action), minoxidil (different mechanism but similar indications for alopecia), silodosin (different mechanism but similar indications for BPH). It was examined whether the detected signals exist in drug labels in Korea. The total number of adverse eventdrug pairs was reported 2,665,429 from 2013 to 2017, of which 1,426 were associated with finasteride. The number of investigated signals of finasteride was 42. The signals that did not include in the drug label were 29 signals, including mouth dry, hypotension, dysuria etc. The signal of finasteride was similar to that of dutasteride and silodosin but was different to that of minoxidil. Early detection of signals through pharmacovigilance is important to patient safety. We investigated 29 signals of finasteride that do not exist in drug labels in Korea. Further pharmacoepidemiological studies should be needed to evaluate the signal causality with finasteride.
참고문헌 (14)
- Steers WD, "5alpha-reductase activity in the prostate", Urology, 58(6 Suppl 1), pp.17~24 (2001)
- Nguyen DD, "Investigation of suicidality and psychological adverse events in patients treated with finasteride", JAMA Dermatol, 157(1), pp.35~42 (2021)
- "VigiAccessTM"[URL]
- Sica DA, "Minoxidil: an underused vasodilator for resistant or severe hypertension", J Clin Hypertens (Greenwich), 6(5), pp.283~287 (2004)
- Messenger AG, "Minoxidil : mechanisms of action on hair growth", Br J Dermatol, 150(2), pp.186~194 (2004)
- Marks LS, "Rapid efficacy of the highly selective alpha(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia : pooled results of 2 phase 3 studies", J Urol, 189(1Suppl), pp.S122~S128 (2013)
- Evans SJ, "Use of proportional reporting ratios(PRRs)for signal generation from spontaneous adverse drug reaction reports", Pharmacoepidem Drug Saf, 10(6), pp.483~486 (2001)
- Egberts AC, "Use of measures of disproportionality in pharmacovigilance : three Dutch examples", Drug Saf, 25(6), pp.453~458 (2002)
- Lindquist M, "A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database", Drug Saf, 23(6), pp.533~542 (2000)
- 김묘송, "국내 사람유두종바이러스백신 접종 후 자발적 이상반응 보고사례의 Brighton Collaboration 기준 활용 가능성 연구", 한국임상약학회지, 30(1), pp.19~30 (2020), 한국임상약학회[DOI]
- Baig MS, "Finasteride-induced inhibition of 5alpha-reductase type 2 could lead to kidney damageanimal, experimental study", Int J Environ Res Public Health, 16(10), pp.1726~ (2019)
- Abdulmaged M. Traish, "Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm", The World Journal of Men's Health, 38(3), pp.323~337 (2020), 대한남성과학회[DOI]
- Irwig MS, "Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects", J Clin Psychiatry, 73(9), pp.1220~1223 (2012)
- Melcangi RC, "Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious", depressive symptomatology, 2013, pp.10(10), 2598~2603